Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |